Experienced in Urachal Cancer

Helen J. Boyle

Clb
Lyon, FR 
Experienced in Urachal Cancer
Clb
Lyon, FR 
OverviewLocationsClinical Research

Overview

Helen Boyle practices in Lyon, France. Ms. Boyle is rated as an Experienced expert by MediFind in the treatment of Urachal Cancer. Her top areas of expertise are Renal Cell Carcinoma (RCC), Testicular Cancer, Urachal Cancer, Bladder Reconstruction, and Cystectomy.

Her clinical research consists of co-authoring 43 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Urachal Cancer.

Gender
Female

Locations

CLB
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Enrollment Status: Active_not_recruiting
Publish Date: September 05, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.
A Multicentric, Prospective Cohort Study Aiming to Evaluate the Added Value of a Large Molecular Profiling Panel (Panel FoundationOne) Versus a Limited Molecular Profiling Panel (Panel CONTROL) in Advanced Solid Tumors.
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Genetic
Study Phase: Not Applicable
Multicenter Randomized Phase III Study Evaluating the Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies
Multicenter Randomized Phase III Study Evaluating the Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies
Enrollment Status: Terminated
Publish Date: October 22, 2021
Intervention Type: Drug
Study Drug: Denosumab
Study Phase: Phase 3
View 2 Less Clinical Trials

43 Total Publications

Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin.
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 24, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Boyle's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile